-
-
-
-
-
-
-
U.S. FDA Accepts Astellas' sNDA for CRESEMBA® (isavuconazonium sulfate) in Children
-
-
-
-
-
-
-
Astellas' Real-World Evidence Studies Provide Further Insight into Negative Impacts of Vasomotor Symptoms (VMS) Associated with Menopause
67,556 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

